CIP
VNDA icon

Cornerstone Investment Partners’s Vanda Pharmaceuticals VNDA Stock Holding History

Cornerstone Investment Partners’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,456
Closed -$196K – 317
2021
Q3 		$196K Sell
11,456
-2,548
-18% -$44.6K 0.01% 193
2021
Q2 		$301K Buy
14,004
+30
+0.2% +$537 0.02% 132
2021
Q1 		$210K Buy
13,974
+31
+0.2% +$502 0.01% 241
2020
Q4 		$183K Buy
+13,943
New +$168K 0.01% 180

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cornerstone Investment Partners's VNDA Position: Q4 2021 in Review

Cornerstone Investment Partners sold out of Vanda Pharmaceuticals (VNDA) in Q4 2021, closing a stake of 11,456 shares — an estimated $196K sold.

Cornerstone Investment Partners first reported a position in VNDA in Q4 2020 and held it in 4 quarters. The position peaked at $301K in Q2 2021. 198 funds tracked by Wall St. Rank hold VNDA as of Q4 2021.

  • Cornerstone Investment Partners reported no remaining Vanda Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Cornerstone Investment Partners sold 11,456 Vanda Pharmaceuticals shares in Q4 2021, an estimated $196K.
  • Cornerstone Investment Partners first reported a position in Vanda Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • Cornerstone Investment Partners's Vanda Pharmaceuticals position peaked at $301K in Q2 2021.
  • 198 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2021.

Based on Cornerstone Investment Partners's 13F filing for Q4 2021, filed 7 Feb 2022.